Nicholas J. DiBella

Randomized Phase II Study of R-CHOP With or Without Bortezomib in Previously Untreated Patients With Non–Germinal Center B-Cell–Like Diffuse Large B-Cell Lymphoma

John P. Leonard, Kathryn S. Kolibaba, James A. Reeves et al. · Journal of Clinical Oncology · 2017 · 187 citations

Relation between chelation and clinical outcomes in lower-risk patients with myelodysplastic syndromes: Registry analysis at 5 years

Roger M. Lyons, Billie J. Marek, Carole Paley et al. · Leukemia Research · 2017 · 47 citations · Full text

Heart Failure, Mixed-phenotype Acute Leukemia, Aplastic Anemia +17

Comparison of 24-month outcomes in chelated and non-chelated lower-risk patients with myelodysplastic syndromes in a prospective registry

Roger M. Lyons, Billie J. Marek, Carole Paley et al. · Leukemia Research · 2013 · 45 citations · Full text

Family Medicine, Prognosis, Aplastic Anemia +22

Randomized Phase 2 Open-Label Study of R-CHOP ± Bortezomib in Patients (Pts) with Untreated Non-Germinal Center B-Cell-like (Non-GCB) Subtype Diffuse Large Cell Lymphoma (DLBCL): Results from the Pyramid Trial (NCT00931918)

John P. Leonard, Kathryn S. Kolibaba, James A. Reeves et al. · Blood · 2015 · 38 citations

Disseminated atypical tuberculosis antedating the clinical onset of neoplasia

Nicholas J. DiBella, Bruce D. Buchanan, Clyde H. Koontz · Cancer · 1977 · 17 citations